(509f) Development of a Kinetic Model of Lipid Metabolism in Saccharomyces Cerevisiae
AIChE Annual Meeting
2020
2020 Virtual AIChE Annual Meeting
Food, Pharmaceutical & Bioengineering Division
Tool Development for Pathway Engineering
Thursday, November 19, 2020 - 9:15am to 9:30am
In order to assimilate more industrially relevant phenotypes and their associated data into the model, we engineered 3 mutants that have been commonly constructed in literature â i) a FFA overproducer with FFA degradation and activation pathways shut off, ii) an intermediate mutant with overexpression in fatty acid biosynthesis flux, and iii) the above overexpression mutant with a heterologous fatty acyl-CoA reductase (FAR) gene that produced fatty alcohols. Timeseries data from these 3 mutants along with the reference strain enabled the construction of a lipid kinetic model that captured the relevant flux distribution through lipid pathways in overproduction mutants. Finally, to probe the lipid networkâs response to perturbations, 13 non-lethal single gene deletions in the glycerophospholipid and sphingolipid submodules were constructed in the reference and 3 overproducing mutants, and the lipidomic profiles from these strains were used to train the model thus capturing the lipid systemâs response to overproduction-relevant mutations.
We performed a priori structural identifiability analysis on the model and utilized it to systematically reduce pathways and species within the model. Practical identifiability analysis performed on the model along with the generated lipidomics datasets was used to design further rounds of experiments and also shed light on the blind spots in the modelâs prediction space. Stability analysis was finally performed on the dynamical system to shed light on the stability of the parameterized mathematical model. Till date, our work represents the richest dataset of lipidomics profiles used to train a kinetic model and has resulted in a model of lipid metabolism that captures engineering-relevant phenotypes. The model is able to successfully emulate the lipid profiles of overproducing mutants reported in earlier studies while providing an explanation for the failure of certain engineering strategies towards overproduction and, to our knowledge, is the first such model to do so. We show how the model can be used to glean insight into the effect of lipid network modifications on overproduction phenotypes and design metabolic engineering strategies for future studies, thus filling a vital gap in the field of lipid metabolic engineering.